Teriflunomide and Epstein-Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response.

Frontiers in immunology(2023)

引用 0|浏览8
暂无评分
摘要
Treatment with teriflunomide was associated with a reduction of the levels of IgG antibody titers against EBV and HHV-6. Furthermore, higher EBNA-1 IgG titers prior to teriflunomide initiation were associated with a better clinical response.
更多
查看译文
关键词
multiple sclerosis, teriflunomide, biomarker, EDSS, EBV, HHV-6, NF-L, ELISA
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要